Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

931
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
931
Neural Regulation01:37

Neural Regulation

43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease-associated microglia in neurodegenerative diseases: Friend or foe?

PLoS biology·2025
Same author

Clearance Pathways for α-Synuclein in Parkinson's Disease.

Journal of neurochemistry·2025
Same author

<i>Drosophila</i> aux orchestrates the phosphorylation-dependent assembly of the lysosomal V-ATPase in glia and contributes to SNCA/α-synuclein degradation.

Autophagy·2025
Same author

New Atg9 Phosphorylation Sites Regulate Autophagic Trafficking in Glia.

ASN neuro·2025
Same author

A Pvr-AP-1-Mmp1 signaling pathway is activated in astrocytes upon traumatic brain injury.

eLife·2024
Same author

The autophagy protein Atg9 functions in glia and contributes to parkinsonian symptoms in a <i>Drosophila</i> model of Parkinson's disease.

Neural regeneration research·2023

Related Experiment Video

Updated: Jan 6, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.6K

Microglia in Parkinson's Disease.

Margaret S Ho1

  • 1School of Life Science and Technology, ShanghaiTech University, #B416, L Building, #230 Haike Road, Pudong New District, Shanghai, 201210, China. margareth@shanghaitech.edu.cn.

Advances in Experimental Medicine and Biology
|October 5, 2019
PubMed
Summary

Microglia, the brain's immune cells, play a dual role in Parkinson's disease (PD). They can both protect and harm by modulating inflammation and clearing protein aggregates like alpha-synuclein.

Keywords:
Alpha-synucleinMicrogliaNeuroinflammationParkinson’s diseasePhagocytosis

More Related Videos

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
11:19

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

4.9K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.9K

Related Experiment Videos

Last Updated: Jan 6, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.6K
Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
11:19

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

4.9K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.9K

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the primary immune cells of the central nervous system (CNS).
  • They perform essential physiological functions, including synaptic pruning and neural circuit remodeling.
  • In disease states, microglia activation is implicated in neuroinflammation and neurodegeneration.

Purpose of the Study:

  • To provide an overview of microglial functions in the context of Parkinson's disease (PD).
  • To discuss the role of microglia-mediated inflammation and phagocytosis in PD pathology.
  • To explore the interaction between microglia, alpha-synuclein, and PD-associated genes.

Main Methods:

  • Literature review and synthesis of existing research on microglia in PD.
  • Discussion of molecular mechanisms, including receptors and signaling pathways.
  • Analysis of microglial involvement in neuroinflammation and phagocytosis of alpha-synuclein.

Main Results:

  • Microglia are activated in Parkinson's disease, migrating to injury sites and interacting with pathological hallmarks.
  • Microglia contribute to PD progression through inflammatory responses and phagocytosis of alpha-synuclein (α-Syn).
  • Specific receptors and signaling pathways mediate microglial responses in PD.

Conclusions:

  • Microglia are critical players in Parkinson's disease pathogenesis, influencing disease progression.
  • Understanding microglial mechanisms offers potential therapeutic targets for PD.
  • Microglial activity, including inflammation and phagocytosis, significantly impacts PD.